Outcome of hepatitis B e antigenβnegativ
β
George V. Papatheodoridis; Evangelini Dimou; Konstantinos Dimakopoulos; Spilios
π
Article
π
2005
π
John Wiley and Sons
π
English
β 415 KB
π 1 views
We determined the clinical outcome of hepatitis e antigen (HBeAg)-negative chronic hepatitis B patients treated with long-term nucleos(t)ide analog therapy starting with lamivudine. We evaluated 201 such patients treated for 3.8 Ψ 1.4 years and 2 historical similar cohorts: 1 treated with interferon